9/22/2019
`
`Masimo - Awards
`
`CX-1378
`
`RECOGNITION FOR EXCELLENCE
`
`
`
`Masimo Rad-97™ Wins 2019 BIG Innovation Award
`
`iisllectual
`
` Pouandinthon
`
`Masimo Founder and CEO Joe Kiani Honored with First IP Champion Award bythe Intellectual
`Property Owners Education Foundation
`
` e
`
`Masimo Wins Participation in the FDA Innovation Challenge to Develop Devices that Prevent and
`Treat Opioid Use Disorder
`
`https /Avww.masimo.com/company/masimo/awards/
`
`PAGE 1 OF 94
`
`1/94
`
`MASITC_01073399
`
`MASIMO2022
`Apple v. Masimo
`IPR2022-01300
`
`MASIMO 2022
`Apple v. Masimo
`IPR2022-01300
`
`

`

`9/22/2019
`
`Masimo - Awards
`
`CX-1378
`
`
`
`seencncneggeeas
`
`
` 3
`
`Masimo Awarded Best Patient Monitoring Technology Manufacturer 2018 by Global Health &
`Pharma
`
`
`
`Masimo CEO Joe Kiani Selected Person of the Year —- SafeCare Magazine
`
`
`
`Masimo Root Wins the GOLD 2015 Medical Design Excellence Award
`
`
`
`Newborn Foundation Bestows Masimo CEO Joe Kiani with the Hubert H. Humphrey ‘DawnofLife’
`Award
`
`https /Avww.masimo.com/company/masimo/awards/
`
`PAGE 2 OF 94
`
`2/94
`
`MASITC_01073400
`
`MASIMO2022
`Apple v. Masimo
`IPR2022-01300
`
`MASIMO 2022
`Apple v. Masimo
`IPR2022-01300
`
`

`

`9/22/2019
`
`Masimo - Awards
`
`CX-1378
`
`Mosplial Review
`
`50 Experts Leading the Field of Patient Safety (2014), includes Masimo CEO and Patient Safety
`Movement Foundation founder Joe Kiani
`
` ZENITH
`
`AWARE 20
`
`Masimo Receives 2013 Zenith Award at the American Association of Respiratory Care Congress
`
`
`
`EMMA™ Paim Size Capnograph Earns 2013 EMS World Top Innovation Award
`
`
`
`Masimo CEO Joe Kiani Receives Argyros Medal for Visionary Leadership & Commitment to Patient
`Safety
`
`https /Avww.masimo.com/company/masimo/awards/
`
`PAGE 3 OF 94
`
`3/94
`
`MASITC_01073401
`
`MASIMO2022
`Apple v. Masimo
`IPR2022-01300
`
`MASIMO 2022
`Apple v. Masimo
`IPR2022-01300
`
`

`

`9/22/2019
`
`Masimo - Awards
`
`CX-1378
`
`
`
`iSpO2, EMMA Earn Hot Products Awards at EMS Today 2013
`
`BY Fees? & YOUNG
`
`Ernst & Young National Entrepreneur Of The Year — 2012 Life Sciences Award Winner
`
`
`
`Masimo Pronto-7® Wins GOLD "Stevie®" Award for Best New Health Product
`
`BU PRAST& YOUN
`
`2012 Ernst & Young Entrepreneur of the Year
`
`https /Avww.masimo.com/company/masimo/awards/
`
`PAGE 4 OF 94
`
`4194
`
`MASITC_01073402
`
`MASIMO2022
`Apple v. Masimo
`IPR2022-01300
`
`MASIMO 2022
`Apple v. Masimo
`IPR2022-01300
`
`

`

`CX-1378
`
`9/22/2019
`
`Masimo - Awards
`
`
`
`2011 TechAmerica High-Tech Innovation Award for the Masimo Pronto-7
`
`
`
`2011 Medical Design Excellence Award - Gold for the Masimo Pronto-7
`
`2011 iF Product Design Award
`
`2010 AARC Zenith Award
`
`
`
`
`
`
`
`Masimo Wins GHX 2010 Respiratory Product Best-in-Class Award
`
`https /Avww.masimo.com/company/masimo/awards/
`
`PAGE 5 OF 94
`
`5/94
`
`MASITC_01073403
`
`MASIMO2022
`Apple v. Masimo
`IPR2022-01300
`
`MASIMO 2022
`Apple v. Masimo
`IPR2022-01300
`
`

`

`9/22/2019
`
`Masimo - Awards
`
`CX-1378
`
`
`
`2009 North American Patient Monitoring CEO of the Year Award
`
`2009 AARC Zenith Award
`
`
`
`
`
`Masimo Patient SafetyNet Helps Dartmouth-Hitchcock Medical Center Win 4th Annual Health
`Devices Achievement Award from ECRI Institute
`
`
`
`Batter health for
`
`
`
` Your Batten
`
`Masimo Wins GHX 2009 Best in Class Award
`
`2008 AARC Zenith Award
`
`https /Avww.masimo.com/company/masimo/awards/
`
`
`
`PAGE 6 OF 94
`
`6/94
`
`MASITC_01073404
`
`MASIMO2022
`Apple v. Masimo
`IPR2022-01300
`
`MASIMO 2022
`Apple v. Masimo
`IPR2022-01300
`
`

`

`CX-1378
`
`9/22/2019
`
`Masimo - Awards
`
`
`
`Medical Technology
`Associationof Australis
`
`2008 MTAA Masimo Honored for Excellence in Medical Technology
`
`
`
`2008 ACG Honors Masimo with Outstanding Growth Award
`
`
`
`axing the Business of Technology
`
`2008 AEA Outstanding Medical Device Company Award
`
` Be
`
`Masimo Wins GHX 2008 Best in Class Award
`
`
`
`2008 Masimo Ranks#1 in Industry Current Impact and Innovation Cycle Time on the Patent
`Scorecard™
`
`https /Avww.masimo.com/company/masimo/awards/
`
`PAGE 7 OF 94
`
`TIQ4
`
`MASITC_01073405
`
`MASIMO2022
`Apple v. Masimo
`IPR2022-01300
`
`MASIMO 2022
`Apple v. Masimo
`IPR2022-01300
`
`

`

`9/22/2019
`
`Masimo - Awards
`
`CX-1378
`
`
`
`WER LEW A
`
`2007 Frost & Sullivan Recognizes Masimo as an Outstanding Companyfor Excellence in
`Healthcare Oppertunities
`
`
`
`2007 Frost & Sullivan North American Patient Monitoring Technology Leadership of the Year Award
`
`HOST G SULLIVAN
`
`
`
`
`
`2007 Frost & Sullivan North American Brand Development Strategy Leadership Award
`
`
`
`2007 Texas Society for Respiratory Care (TSRC) LoneStar Award
`
`https /Avww.masimo.com/company/masimo/awards/
`
`PAGE 8 OF 94
`
`8/94
`
`MASITC_01073406
`
`MASIMO2022
`Apple v. Masimo
`IPR2022-01300
`
`MASIMO 2022
`Apple v. Masimo
`IPR2022-01300
`
`

`

`CX-1378
`
`9/22/2019
`
`Masimo - Awards
`
`
`
`2007 STA Excellence in Technology Innovation Award
`
`
`
`2006 Orange County Business Journal Excellence in Entrepreneurship Award
`
`
`
`2006 Medical Design Excellence Award for the Masimo Rad-57
`
`
`
`Aahwmaing tite bhustseas of Tending
`
`AEA 2006 High Tech Award Winner - Medical Technology Award
`
`2006 Application of Technology Award
`
`https /Avww.masimo.com/company/masimo/awards/
`
`
`
`PAGE 9 OF 94
`
`9/94
`
`MASITC_01073407
`
`MASIMO2022
`Apple v. Masimo
`IPR2022-01300
`
`MASIMO 2022
`Apple v. Masimo
`IPR2022-01300
`
`

`

`9/22/2019
`
`Masimo - Awards
`
`CX-1378
`
`
`
`Masimo Tops the 2006 Patent Scorecard’s Top 10 List of Innovators in Medical Devices for Current-
`Impact Index™ and Technology Cycle Time™
`
` SAN DIEGO
`
`STATE
`LUNIVERSITY
`
`2005 San Diego State University - Monty Award
`
`
`
`2005 Deloitte & Touche - Technology Fast 50, Orange County
`
` BS Daghedte
`
`2004 MD & DI 100 Notable People in Medical Device Industry awarded to Joe Kiani
`
`
`
`ORUM
`CORPORAT
`
`
`for
`Y CURES
`
`2004 The Forum for Corporate Directors -- Director of the Year for Corporate Growth
`
`https /Avww.masimo.com/company/masimo/awards/
`
`PAGE 10 OF 94
`
`10/94
`
`MASITC_01073408
`
`MASIMO2022
`Apple v. Masimo
`IPR2022-01300
`
`MASIMO 2022
`Apple v. Masimo
`IPR2022-01300
`
`

`

`9/22/2019
`
`Masimo - Awards
`
`CX-1378
`
`
`
`2004 Deloitte & Touche 2004 Technology Fast 50, Orange County
`
`Re eeee rer
`
`2003 Frost & Sullivan New Standard of Care in Patient Monitoring Award
`
`
`
`2003 Frost & Sullivan Patient Monitoring Technology of The Year Award
`
` Lo #igotves Quainess Loaders
`
`ag Pagers
`
`ayy
`
`2003 Platinum "ABBY" Award --Acaptive Business Leaders Innovations in Healthcare Award
`
`
`
`https /Avww.masimo.com/company/masimo/awards/
`
`PAGE 11 OF 94
`
`11/94
`
`MASITC_01073409
`
`MASIMO2022
`Apple v. Masimo
`IPR2022-01300
`
`MASIMO 2022
`Apple v. Masimo
`IPR2022-01300
`
`

`

`CX-1378
`
`9/22/2019
`
`Masimo - Awards
`
`2002 Frost & Sullivan Product Quality Leadership Award
`
`
`
`2001 Audie Lewis Mark of Excellence Award
`
`
`
`Aahouncing tie Buvetons ag Seeding
`
`2001 AEA Innovative Product/Technology Award
`
`
`
`2001 The Huntington's Disease Society of America Distinguished Leadership Awara
`
`https /Avww.masimo.com/company/masimo/awards/
`
`PAGE 12 OF 94
`
`12/94
`
`MASITC_01073410
`
`MASIMO2022
`Apple v. Masimo
`IPR2022-01300
`
`MASIMO 2022
`Apple v. Masimo
`IPR2022-01300
`
`

`

`CX-1378
`
`9/22/2019
`
`Masimo - Awards
`
`Saeing babies,daguiliere
`
`March
`ofDimess
`
`2001 March of Dimes Excellence in Leadership Award
`
`
`Societyof
`Critical Care Medicine
`
`2000 SCCM Technology Excellence Award
`
`
`
`2000 Frost & Sullivan Market Engineering Competitive Strategy Award
`
`
`
`Aubaanaiing tite Ghastsesoff
`
`Henhodigye
`
`2000 AEA High Tech Award Winner- Outstanding Medical Device Company
`
`
`
`1995 STA Excellence in Technology Innovation Award
`
`https /Avww.masimo.com/company/masimo/awards/
`
`PAGE 13 OF 94
`
`13/94
`
`MASITC_01073411
`
`MASIMO2022
`Apple v. Masimo
`IPR2022-01300
`
`MASIMO 2022
`Apple v. Masimo
`IPR2022-01300
`
`

`

`CX-1378
`
`9/22/2019
`
`Masimo - Awards
`
`Masimo Rad-97™ Wins 2019 BIG Innovation Award
`
`Philadelphia, Pennsylvania — February 5, 2019 - Masimo announced
`
`that its Rad-97™ Pulse CO-Oximeter® is among the winners of the
`
`Business intelligence Group’s 2019 BIG Innovation Award, an annual
`
`business award that recognizes the organizations, products and
`
`people that are bringing newideasto life. “Innovation and the use of
`
`
`
`technology to advance commerce and improvelives is permeating nearly every organization
`
`acrossthe globe,” said Maria Jimenez, chief operating officer of the Business Intelligence Group.
`
`“Wearethrilled to be honoring this year’s winning executives, companies and products as they
`
`work to improve our experiences and lives.” The Business Intelligence Group was founded with
`
`the mission of recognizing true talent and superior performancein the business world. The
`
`organization’s proprietary and unique scoring system selectively measures performance across
`
`multiple business domains and then rewards those companies whose achievements stand above
`
`those of their peers.
`
`GO TO TOP
`
`
`
`
`Masimo Founder and CEO Joe Kiani Honored with First IP Champion Award by the Intellectual
`sethectoal
`
`
`
`Property Owners Education Foundation
`
`
`
`Washington, DC — December 12, 2018 - Masimo Founder and CEO Joe
`
`Kiani was honored last night at the 2018 IPO Education Foundation Awards Dinnerwith the first
`
`ever IP Champion Award. The Intellectual Property Owners Education Foundation, a non-profit
`
`organization devoted to educating the public on the importanceofIP to society, has been
`
`awarding an Inventor of the Year for 45 years and Distinguished IP Professional for 10 years.
`
`2018 marks the creation of a new award, IP Champion, bestowed upon Mr. Kiani for showing
`
`“extraordinary leadership in advocating for the value of intellectual property to the progress of
`
`innovation.”
`
`Retired Chief Judge Paul Michel, formerly U.S. Circuit Judge of the U.S. Court of Appeals for the
`
`Federal Circuit and Chief Judge of that court, commented, “Serial inventor Joe Kiani built a major
`
`https /Avww.masimo.com/company/masimo/awards/
`
`PAGE 14 OF 94
`
`14/94
`
`MASITC_01073412
`
`MASIMO2022
`Apple v. Masimo
`IPR2022-01300
`
`MASIMO 2022
`Apple v. Masimo
`IPR2022-01300
`
`

`

`CX-1378
`
`9/22/2019
`
`Masimo - Awards
`
`patient health improving company, starting from scratch at age 23, obtaining VC funding based
`
`on his patent applications when patents were strong. Later Congressional and Supreme Court
`
`interventions so sapped patent strength that he could not repeat his feat today. Reviving patents
`
`is essential to America's future since most major inventions, new jobs, and personal welfare
`
`gains and economic growth result from start-ups and small and mid-sized technology companies
`
`like Masimo. It actually saves many lives each day with its patient monitoring devices. Isn't that
`
`what we need as much today as before?”
`
`GO TO TOP
`
`
`
`Masimo Wins Participation in the FDA Innovation Challenge to Develop Devices that Prevent and
`
`Treat Opioid Use Disorder
`
`Irvine, California - December 3, 2018 — Masimo is one of eight U.S.
`
`
`=I
`
`[ae
`
`companiesto be selected for the FDA Innovation Challenge: Devices
`
`to Prevent and Treat Opioid Use Disorder. Initially announced in May, this Innovation Challenge
`
`is designed to spur the development of medical devices to help combat the opioid crisis and
`
`achieve the goal of preventing and treating opioid use disorder. From over 250 applications, 8
`
`medical device developers were selected to participate, including Masimo.
`
`In a statement, the FDA noted that “Through this effort, the FDA seeks to provide device
`
`developers an opportunity to work directly with the FDA to accelerate the developmentof
`
`innovative products, such as diagnostics to identify patients at increased risk for addiction, non-
`
`opioid pain therapies for acute or chronic pain, treatments for opioid use disorder or symptoms of
`
`opioid withdrawal, as well as devices that monitor the use and prevent diversion of prescription
`
`opioids.” Masimo and the other winners will work directly with the FDA to accelerate the
`
`development and review of innovative products, which will be eligible for “Breakthrough Device”
`
`designation.
`
`
`
`
`
`GO TO TOP
`
`PAGE 15 OF 94
`
`https /Avww.masimo.com/company/masimo/awards/
`
`15/94
`
`MASITC_01073413
`
`MASIMO2022
`Apple v. Masimo
`IPR2022-01300
`
`MASIMO 2022
`Apple v. Masimo
`IPR2022-01300
`
`

`

`CX-1378
`
`9/22/2019
`
`Masimo - Awards
`
`Masimo Awarded Best Patient Monitoring Technology Manufacturer 2018 by Global Health &
`
`Pharma
`
`Irvine, California - September 14, 2018 — Masimo announced thatit has received this year’s
`
`Healthcare & Pharmaceutical Award for “Best Patient
`
`Monitoring Technology Manufacturer 2018,” as determined
`
`by Global Health & Pharma (GHP). GHP is a UK-based,
`
`global information sharing platform of approximately 4,900
`
`
`
`users dedicated to enhancing communication and collaboration across a variety of healthcare
`
`themes. The Healthcare & Pharmaceutical Awards celebrate those companies which
`
`demonstrate dedication to furthering advancements within healthcare, and are given based
`
`solely on merit.
`
`GO TO TOP
`
`
`
`
`
`SafeCare Magazine Selects Joe Kiani as Person of the Year
`
`(/siteassets/us/documents/pdf/cover-story-safe-care. pdf)
`
`Lexington, Kentucky — October 5, 2015 — SafeCare
`
`Magazine announced today that Joe Kiani, Founder of the
`
`Patient Safety Movement Foundation and CEO of Masimo,
`was awarded Personof the Year for 2015. This award
`
`recognizes and applauds the one individual who contributed
`
`significantly towards improving patient safety and healthcare
`
`quality across the globe.
`
`President, Institute of Medicine of the National Academy of
`
`The 64 nominees and finalists included Dr. Victor Dzau,
`
`Sciences, Dr. James Bagian, former astronaut, Director,
`
`Center for Healthcare Engineering, University of Michigan,
`
`Dr. Atul Gawande, Surgeon and public health researcher, Dr. Peter Pronovost, SVP for Patient
`
`Safety and Quality, Johns Hopkins University of Medicine, Dr. Mark Chassin, President of the
`
`Joint Commission, Dr. Ala Alwan, World Health Organization, Dr. Patrick Conway, Chief Medical
`
`Officer for Medicare, Dr. Cynthia Deyling, Chief Quality Officer, Cleveland Clinic Health Systems,
`
`Dr. David Bates, Chief Innovation Officer, Brigham and Women's Hospital, Dr. Rabert M.
`
`https /Avww.masimo.com/company/masimo/awards/
`
`PAGE 16 OF 94
`
`16/94
`
`MASITC_01073414
`
`MASIMO2022
`Apple v. Masimo
`IPR2022-01300
`
`MASIMO 2022
`Apple v. Masimo
`IPR2022-01300
`
`

`

`9/22/2019
`
`Masimo - Awards
`
`Wachter, Professor and Interim Chairman, Department of Medicine at University of California San
`
`Francisco, and Dr. Hardeep Singh, Chief, Health Policy, Quality and Informatics Program,
`
`Houston Veteran Affairs Health Services Research Center for Innovation.
`
`“We congratulate this year’s 2015 SafeCare Person of the Year - Mr. Kiani,” said Dr. Yisrael M.
`
`Safeek, Founder of SafeCare Magazine. “Weare incredibly impressed with what he has been
`
`able to accomplish in the area of patient safety. Most of our nominees were internationally
`
`recognized physicians so the very fact that this year’s award is going to someone without a
`
`medical background makes him even more remarkable. For over 25 years, his innovations have
`
`revolutionized surgery and critical care medicine. His work with his non-profit Patient Safety
`
`Movement Foundation has taken the topic of patient safety and putit at the forefront of those that
`
`can impact change. If anyone can achieve zero preventable deaths by 2020, it will be Mr. Joe
`
`Kiani.”
`
`SafeCare Magazine’s missionis to deliver information on the people, ideas, organizations and
`
`novel technologies affecting safe, efficient and quality healthcare to the sector’s mostinfluential
`
`leaders. The publication’s 100 SafeCare Hospital ranking is firmly rooted in the evidence-based
`
`frameworkof the Affordable Care Act, evaluating hospitals in HVBP, HRRP, and HACRP metrics.
`
`For more information, please visit www.safecaremagazine.com
`
`(http://www.safecaremagazine.com).
`
`GO TO TOP
`
`
`
`Masimo Root Wins the GOLD 2015 Medical Design Excellence Award
`
`IRVINE, California — June 10, 2015 — Masimo (NASDAQ: MASI) announcedthat its Root* patient
`
`monitoring and connectivity platform has received the GOLD 2015 Medical Design Excellence
`
`Award—the highest award given in the general hospital devices and therapeutic products
`
`category. The 2015 Medical Design Excellence Award winners were honored today ata
`
`presentation ceremonyin New York City’s Jacob K. Javits Convention Center, in conjunction with
`
`the Medical Design & Manufacturing (MD&M) East Conference and Exposition
`
`(www. MDMEast.com (http://trk.co20.com/Tracking/t.c?8d5pm-odo2z-lent0i9&_v=2)).
`
`Root comes with a dock for the Radical-7* handheld monitor or Radius-7® wearable monitor, an
`
`intuitive display, and multiple networking/connectivity options. Root integrates multiple streams of
`
`CX-1378
`
`
`
`data on an easy-to-read, touch-screen.
`
`https /Avww.masimo.com/company/masimo/awards/
`
`PAGE 17 OF 94
`
`17/94
`
`MASITC_01073415
`
`MASIMO2022
`Apple v. Masimo
`IPR2022-01300
`
`MASIMO 2022
`Apple v. Masimo
`IPR2022-01300
`
`

`

`9/22/2019
`
`Masimo - Awards
`
`Rootinnovations include:
`
`« MOC-9™ — Flexible measurement expansion through Masimo Open Connect™ (MOC-9™) with MOC-9
`modules from Masimo or third-party measurement by other companies to expandthe platform’s
`measurements and capabilities. New MOC-9 modules in the U.S. will require new 510(k) clearances
`ISA™ Capnography — CO2 sidestream module featuring fast warm-up time and the innovative and cost-
`effective Nomoline™ sampling line
`e SedLine® brain function monitoring module, which provides four channels of EEG to help clinicians better
`understand the effects of anesthesia on the brain<
`
`e
`
`«
`
`fris™ connectivity gateway designed to provide integration for standalone devices such as IV pumps,
`
`ventilators, hospital beds, and other patient monitors. Iris enables Root to intake data from all devices
`
`connected to the patient, acting as an in-room patient monitor and connectivity hub. Alarms and alerts
`
`for all devices are seamlessly forwarded to the patient's clinician and all device data are effortlessly
`
`documented in the patient's electronic medical record
`
`e Wireless functionality - Capable of transmitting information through Bluetooth and WiFi.
`
`Root (/products/continuous/root/) can accommodate
`
`Radical-7 or Raidus-7
`
`(/products/continuous/radius7/), the first and only
`
`wearable, wireless monitor with Masimo’s
`
`breakthrough rainbow® SET® technology, to
`
`measure blood oxygenation, pulse rate, and
`
`CX-1378
`
`
`
`rainbow® acoustic monitoring (RAM™) through acoustic respiration rate (RRa®). Radius-7 offers
`
`la.
`.
`coy
`.
`.
`patients continuous monitoring while providing
`
`idasime Reat®patient mantloring and commachvity hab wih
`the Radine- 7"patient-worn, wireless moniter.
`
`freedom of movement, allowing hospitals to
`
`optimize capacity by getting patients out of bed faster. Studies have shown that patient mobility is
`
`a key factor in more rapid patient recovery.’
`
`The Medical Design Excellence Awards competition (www.MDEAwards.com
`
`(http://trk.cp20.com/Tracking/t.c?8d5pm-odo32-lent0i8&_v=2)) is organized and presented by
`
`UBM Canonand is the only awards program that exclusively recognizes contributions and
`
`advancesin the design of medical products. Entries are evaluated on the basis of their design
`
`and engineering features, including innovative use of materials, user-related functions that
`
`improve healthcare delivery and changetraditional medical attitudes or practices, features that
`
`provide enhanced benefits to the patient, and the ability of the product development team to
`
`overcome design and engineering challenges so that the product meetsits clinical objectives. A
`
`comprehensive review of the entries was performed by an impariial, multidisciplinary panel of
`
`third-party jurors with expertise in biomedical engineering, humanfactors, industrial design,
`
`medicine, and diagnostics.
`
`https /Avww.masimo.com/company/masimo/awards/
`
`PAGE 18 OF 94
`
`18/94
`
`MASITC_01073416
`
`MASIMO2022
`Apple v. Masimo
`IPR2022-01300
`
`MASIMO 2022
`Apple v. Masimo
`IPR2022-01300
`
`

`

`CX-1378
`
`9/22/2019
`
`Masimo - Awards
`
`“We are honored to have Root receive the GOLD MDEA-winning product,” said Joe Kiani,
`
`Founder and CEO of Masimo. “We hope Rootwill eliminate barriers to entry for innovative
`
`products and barriers to interoperability and help automate patient care with its open and
`scalable architecture.”
`
`@Masimolnnovates (http:/trk.cp20.com/Tracking/t.c?8d5pm-odo33-lent0i9&_v=2) || #Masimo
`
`"Needham D, Korupolu R, Zanni J, Pradhan P, Colantuoni E, Palmer J, Brower R, Fan E. “Early Physical Medicine and Rehabilitation for
`Patients With Acute Respiratory Failure: A Quality Improvement Project.” Archives of Physical Medicine and Rehabilitation Vol 91, Issue
`4, PP 536-542, April 2010
`
`About Masimo
`
`Masimo (NASDAQ: MASI) is the global leader in innovative noninvasive monitoring technologies that significantly improve patient care-
`helping solve "unsolvable" problems. In 1995, the company debuted Measure-through Motion and Low Perfusion pulse oximetry, known
`as Masimo SET®, which virtually elirninated false alarms and increased pulse oximetry's ability to detectlife-threatening events. More
`than 100 indepensdent and objective studies have shown that Masimo SET® outperforms other pulse oximetry technologies, even under
`the most challenging clinical conditions, including patient motion and low peripheral perfusion. In 2005, Masimo introduced rainbow
`Pulse CO-Oximetry technology, allowing noninvasive and continuous monitoring of blood constituents that previously could only be
`measured invasively, including total hemaglobin (SpHb®), oxygen content (SpOC™), carboxyhemoglobin (SpCO®), methemoglobin
`(SpMet®), and Pleth Variability Index (PVi®),
`in addition to SpOz2, pulse rate, and perfusion index (Pl). Additional information about
`Masimoand its products may be found at www.masimo.com (http:/Awww.masimo.com).
`
`Forward-Looking Statements
`This press release includes forward-looking statements as defined in Section 27A of the Securities Act of 1933 and Section 21E of the
`Securities Exchange Act of 1934, in connection with the Private Securities Litigation Reform Act of 1995. These forward-looking
`statements are based on current expectations about future events affecting us and are subject to risks and uncertainties, all of which are
`difficult to predict and many of which are beyond our control and could cause our actual results to differ materially and adversely from
`those expressed in our forward-looking statements as a result of various risk factors discussed in the "Risk Factors" section of our most
`recent reports filed with the Securities and Exchange Commission ("SEC"), which maybe obtainedfor free at the SEC's website at
`www.sec.gov (http:/Ark.cp20.com/Tracking/t.c?8d5prn-odo35-lent0i1&_v=2). Although we believe that the expectations reflected in our
`forward-looking statements are reasonable, we do not know whether our expectations will prove correct. All forward-looking statements
`included in this press release are expressly qualified in their entirety by the foregoing cautionary statements. You are cautioned not to
`place undue reliance on these forward-looking statements, which speak only as of today’s date. We do not undertake any obligation to
`update, amendor clarify these statements or the "Risk Factors" contained in our most recent reportsfiled with the SEC, whether as a
`result of new information, future events or otherwise, except as may be required under the applicable securities laws.
`
`GO TO TOP
`
`
`
`
`
`
`
`Newborn Foundation Bestows Masimo CEO Joe Kiani with the Hubert H. Humphrey ‘Dawnof
`
`Life’ Award
`
`Awards Gala Marked Largest Fundraiserofits Kind to Raise Awareness to Combat Newborn
`
`Mortality
`
`https /Avww.masimo.com/company/masimo/awards/
`
`PAGE 19 OF 94
`
`19/94
`
`MASITC_01073417
`
`MASIMO2022
`Apple v. Masimo
`IPR2022-01300
`
`MASIMO 2022
`Apple v. Masimo
`IPR2022-01300
`
`

`

`9/22/2019
`
`Masimo - Awards
`
`Irvine, California — Oct. 13, 2014 —The Newborn Foundation presented
`
`Joe Kiani, founder, CEO and Chairman of the Board of Masimo
`
`
`
`(NASDAQ: MAS)), with the Hubert H. Humphrey “Dawn of Life” Award at its gala Friday night in
`
`Minneapolis, Minn., an honor previously reserved for members of Congress.
`
`Billed as the largest fundraiser ofits kind to raise awareness for combatting newborn mortality, all
`
`proceeds from the awards gala will go to the continued efforts of the Newborn Foundation |
`
`Coalition to leverage technologies that improve early detection of health conditions and accessto
`care for newborns.
`
`Hubert “Buck” HumphreyIV, the former Vice President's grandson, presented the DawnofLife
`
`award to Kiani as a “visionary leader who has been dedicated to increasing the role of technology
`
`and innovation in improving health” of newborns around the world.
`
`Kiani received the “Dawn ofLife” Award the same day Masimo announced CE Mark of Eve™
`
`Newborn Screening Software Application* for Radical-7® Pulse CO-Oximeters, designed to help
`
`clinicians more effectively and efficiently screen newborns forcritical congenital heart disease
`
`(CCHD).
`
`“Joe’s work has been truly outstanding,” said Annamarie Saarinen, co-founder and CEO of the
`
`Newborn Foundation. “It's been a privilege to have his wisdom and support in pursuit of
`
`improving newborn health and patient safety.”
`
`The Newborn Foundation (http:/Avww.newbornfoundation.org/) was launched after Saarinen’s
`
`daughter, Eve, was diagnosed and treated forcritical congenital heart defects as a newborn. She
`
`was only able to survive because of early detection and accessto life-saving intervention. In just
`
`a few short years, the Newborn Foundation’s advocacy and policy leadership have impacted the
`
`landscape of newborn health — and helped savelives. Today, nearly all 4 million babies born
`
`each year in the U.S. are being screened with pulse oximetry (http://cchdscreeningmap.org/) for
`
`heart defects and other serious health conditions and the Newborn Foundation’s projects are
`
`impacting the hardest to reach anc most underserved babies acrossthe nation.
`
`The Foundation’s work has also expanded internationally, with vital screening, telenealth and
`
`infrastructure programs in Morocco, the Philippines and rural China. A partner of the United
`
`Nations’ Every Newborn Action Plan
`
`(htip://www.everynewborn.org/Documents/ENAP_committments-RA.pdf)— Masimo and the
`
`Newborn Foundation’s BORN Project (htto:/Avwww.newbornfoundation.org/born-project)were
`
`highlighted at a global meeting of delegates in Johannesburg this year as being among a handful
`
`of programsthat are saving newbornlives.
`
`https /Avww.masimo.com/company/masimo/awards/
`
`PAGE 20 OF 94
`
`20/94
`
`MASITC_01073418
`
`MASIMO2022
`Apple v. Masimo
`IPR2022-01300
`
`CX-1378
`
`
`
`MASIMO 2022
`Apple v. Masimo
`IPR2022-01300
`
`

`

`9/22/2019
`
`Masimo - Awards
`
`Stated Kiani: “lam truly humbled and honored to receive the Newborn Foundation’s ‘Dawnof
`
`Life’ Award. The Newborn Foundationis a tireless advocate for those who can’t yet speak for
`
`themselves — babies born with heart and other conditions, who can be saved with early detection
`
`and intervention. |, and all of us at Masimo, look forward to continue working alongside the
`
`Newborn Foundation, with the goal of eliminating preventable deaths of newborns.”
`
`CX-1378
`
`Eve™ js not available in the United States.
`
`* Referred to as “CCHD Mode’in Radical-7
`
`About the Newborn Foundation
`
`The Newborn Foundation is an international non-profit working specifically to leverage health IT and medical technologies to improve
`access and outcomeswhile reducing disparities for newborns. The organization has been integral in the policy development, adoption
`and implementation of technologies for early detection, intervention and care of the youngest patients, including the landmark addition of
`universal newborn screening with pulse oximetry as a public health initiative. The work has now moved international, with vital newborn
`health projects in the UK, Morocco, the Philippines and rural China. Visit www.newbornfoundation.org
`(htip://www.newbornfoundation.org)
`
`About Masimoge:
`Masimo (NASDAQ: MASI) is the global leaderin innovative noninvasive monitoring technologiesthat significantly improve patient care-
`helping solve "unsolvable" problems. In 1995, the company debuted Measure-Through Motion and Low Perfusion pulse oximetry, known
`as Masimo SET®, whichvirtually eliminated false alarms and increased pulse oximetry’s ability to detectlife-threatening events. More
`than 100 independent and objective studies have shown that Masimo SET®outperforms other pulse oximetry technologies, even under
`the most challenging clinical conditions, including patient motion and low peripheral perfusion. In 2005, Masimo introduced rainbow SET®
`Pulse CO-Oximetry technology, allowing noninvasive and continuous monitoring of blood constituents that previously could only be
`measured invasively, including total hermaglobin (SpHb®), oxygen content (SpOC™), carboxyhemoglobin (SpCO*), methemoglobin
`(SpMet®), and Pleth Variability Index (PVi*),
`in addition to SpO2, pulse rate, and perfusion index (P1). Additional information about
`Masimoand its products may be found atwww.masimo.com.
`
`Forward Looking Statements
`This press release includes forward-looking statements as defined in Section 27A of the Securities Act af 1933 and Section 21E of the
`Securities Exchange Act of 1934, in connection with the Private Securities Litigation Reform Act of 1995. These forward-looking
`statements are based on current expectations about future events affecting us and are subjectto risks and uncertainties, all of which are
`difficult to predict and many of which are beyond our controi and could cause our actual results to differ materially and adversely from
`those expressed in our forward-looking statements as a result of various risk factors, including, but not limited to: whether Mr. Kiani’s
`receipt of the Dawn of Life award will have any material effect on our business, as well as other factors discussed in the Risk Factors”
`section of our most recent reportsfiled with the Securities and Exchange Commission ("SEC"), which may be obtained for free at the
`SEC's website at www.sec.gov. Although we believe that the expectations reflected in our forward-looking statements are reasonable, we
`da not know whetherour expectations will prove correct. All forward-looking statements included in this press release are expressly
`qualified in their entirety by the foregoing cautionary statements. You are cautioned not to place undue reliance on these forward-looking
`statements, which speak only as of today’s date. We do not undertake any obligation to update, amendorclarify these forward-looking
`staternents or the "Risk Factors" contained in our mast recent reports filed with the SEC, whether as a result of new information, future
`events or otherwise, except as may be required under the applicable securities laws.
`
` —_—
`
`GO TO TOP
`
`https /Avww.masimo.com/company/masimo/awards/
`
`PAGE 21 OF 94
`
`21/94
`
`MASITC_01073419
`
`MASIMO2022
`Apple v. Masimo
`IPR2022-01300
`
`MASIMO 2022
`Apple v. Masimo
`IPR2022-01300
`
`

`

`9/22/2019
`
`Masimo - Awards
`
`Becker's Hospital Review Names 50 Experts Leading the Field of Patient Safety, including
`
`Patient Safety Movement Foundation Founder Joe Kiani
`
`Irvine, California — April 7, 2014 — Becker's Hospital Review has publishedits list HospitalReview
`of “50 Experts Leading the Field of Patient Safety,” recognizing healthcare organizations,
`
`nonprofits, universities and other institutions devoted to improving patient safety and quality of
`
`care. The leaders include healthcare providers, advocates, administrators, researchers and
`
`professors who have demonstrated a commitmentto patient safety through their body of work,
`
`personal accomplishments and organizational leadership.
`
`The Becker's Hospital Review editorial team evaluated experts based cn local and national
`
`impact on patient safety through participating in or heading patient safety initiatives, educating
`
`others, publicly speaking about patient safety and publishing articles and research.
`
`The 20714 roster of “50 Experts Leading the Field of Patient Safety” includes:
`
`JamesP. Bagian, MD, PE. Director for the Center for Health Engineering and Patient Safety,
`
`University of Michigan
`
`David W. Bates, MD, MSc. Senior Vice President for Quality and Safety and Chief Quality Officer
`
`at Brigham and Women’s Hospital and Brigham and Women's Physicians Organization
`
`Donald M. Berwick, MD, MPP. Former CMS Administrator
`
`Karl Bilimoria, MD, MS. Director of Surgical Outcomes and Quality Improvement Center at
`
`Northwestern Memorial Hospital
`
`Leah F. Binder, MA, MGA. CEO of The Leapfrog Group
`
`Maureen Bisognano, RN. President and CEO ofthe Institute for Healthcare Improvement
`
`Doug Bonacum. Vice President of Quality, Safety and Resource Managementat Kaiser
`
`Permanente
`
`Richard Boothman, JD. Chief Risk Officer of University of Michigan Health System
`
`Helga Brake, PharmD, CPHQ. Patient Safety Leader at Northwestern Memorial Hospital
`
`Mark R. Chassin, MD,